Investments
Ardelyx, Inc.
Focused on the discovery and development of novel therapeutics acting exclusively in the gastrointestinal tract and devoid of systemic exposure
Sector: Biopharmaceuticals, Healthcare
Company Status: Private
Investment Status: Current
Associated Team Members:
Ali Behbahani, MD
Board Members:
David Mott